InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.40
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
63,071.02
(
2.64%
)
Post# of 251807
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4538
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 201686

Tuesday, 05/31/2016 6:09:47 PM

Tuesday, May 31, 2016 6:09:47 PM

Post# of 251807

Not to be confused with ENTA’s cyclophilin inhibitor for HCV



It's possible (probable?) that ENTA's cyclophilin inhibitor also has activity against hep B. I know they are pursuing a path in hep C and an alternative MOA for hep B, but most of these drugs have been shown to have activity against both hep B and hep C
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up